Ingredient

Voglibose

Boglitasone is an ingredient used to inhibit the rise in blood sugar after meals in the treatment of diabetes.

All medicines
13
Single ingredient
13
Prescription medication
13

MFDS ingredient code M051790

What does it do?

Boglitasone belongs to the class of alpha-glucosidase inhibitors and is an ingredient used in the treatment of diabetes. It is primarily used to prevent rapid increases in blood sugar after meals. This ingredient helps control blood sugar by delaying the breakdown of carbohydrates in the small intestine.

Boglitasone inhibits the enzyme alpha-glucosidase, which breaks down carbohydrates in the small intestine. As a result, carbohydrates are broken down and absorbed slowly, preventing rapid increases in blood sugar after meals. Consequently, blood sugar control improves.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Unlike other diabetes medications, Boglitasone does not directly stimulate insulin secretion but works by delaying carbohydrate absorption in the digestive process. This aspect favors improvements in insulin resistance and reductions in the risk of hypoglycemia.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.